Commercial newswire·US·
FDA Grants Fast Track Designation for TRE-515 in Combination with KRAS G12C Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Second FDA Fast Track designation expands oncology opportunity and supports expedited development across multiple cancer indications
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- The Pentagon's Chinese Tungsten Ban Starts in 15 Months
- Study Finds Potential Nutrient Density Advantages in Niman Ranch Regenerative Organic Beef
- SKYNEA Makes Global Debut on The Blonds Runway at New York Fashion Week
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →Shared via PPN World — real-time press release intelligence.